Found 240 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
2001
J. Kurtzberg, Wagner, E. L., Gindy, L., Issitt, I., Carter, S. L., Kernan, N. A., Jensen, L., Cairo, M. S., and Fraser, J. K., Characteristics of cord blood collections: the COBLT Study cord blood bank experience, 2001.
H. X. Chen, Gore-Langton, R. E., and Cheson, B. D., Clinical trails referral resource. Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab, Oncology, vol. 15, pp. 1026-36, 2001.
E. L. Trimble, Rowland, J., Varricchio, C., and Gore-Langton, R. E., Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part I), Oncology, vol. 15, pp. 456-861-6, 2001.
E. L. Trimble, Rowland, J., Varricchio, C., and Gore-Langton, R. E., Clinical trials referral resource. Health-related quality of life in cancer clinical trials (Part II), Oncology, vol. 15, pp. 601-3606-8 611, 2001.
A. Murgo, Wood, K. F., Gravell, A. E., and Cheson, B. D., Clinical Trials Referral Resource. STI571, Oncology, vol. 15, no. 7, pp. 881-882, 885-886, 2001.
J. Kurtzberg, Wagner, E. L., Gindy, L., Issitt, I., Carter, S. L., Kernan, N. A., Jensen, L., Cairo, M. S., and Fraser, J. K., The COBLT Study cord blood banking experience: donor recruitment, collection, processing, testing, and banking, 2001.
J. K. Fraser, Wagner, E. L., Carter, S. L., Kernan, N. A., Jensen, L., Rowan, E., and Kurtzberg, J., Cord blood donor pre-screening: Impact of exclusion criteria on minority recruitment, 2001.
B. R. Luce, Zangwill, K. M., Palmer, C. S., Mendelman, P., Yan, L., Wolff, M. C., Cho, I., Marcy, M., Iacuzio, D., and Belshe, R. B., Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children, Pediatrics, vol. 108, p. E24, 2001.
J. Abrams, Gravell, A. E., and Cheson, B. D., Current Cooperative Group Phase III Clinical Trials in Early Stage Breast Cancer, Oncology, vol. 15, no. 2, pp. 176-7, 181-2, 185, 2001.
2000
R. R. Sokol, Oden, N. L., Rosenberg, M. S., and Thomson, B. A., Cancer incidences in Europe related to mortalities, ethnohistoric, genetic, and geographic distances, Proceedings of the National Academy of Science, vol. 97, pp. 6067-72, 2000.
R. Simon, Desper, R., Papadimetriou, C., Peng, A., Alberts, D. S., Taetle, R., Trent, J. M., and Schäffer, A. A., Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis, Genes Chromosomes Cancer, vol. 28, pp. 106-120, 2000.
L. E. Via, Gore-Langton, R. E., and Pluda, J. M., Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416, Oncology, vol. 14, pp. 13121315-16 1321-23, 2000.
J. Wright, Hillsamer, V. L., Gore-Langton, R. E., and Cheson, B. D., Clinical Trials Referral Resource. Current Clinical Trials for the Proteasome Inhibitor PS-341, Oncology, vol. 14, no. 11, pp. 1589-15901593-941597, 2000.
R. S. Kaplan, Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral resource. Current clinical trials in prostate cancer, Oncology, vol. 14, pp. 399-400403-404, 2000.
T. Davis, Gore-Langton, R. E., and Cheson, B. D., Clinical trials referral source. Current clinical trials of the anti- CD20 monoclonal antibody rituximab, Oncology, vol. 14, pp. 14371440-1443, 2000.
B. A. Conley, Gore-Langton, R. E., and Cheson, B. D., Clinical trials resource. Treatment of advanced or recurrent squamous cell carcinoma of the head and neck, Oncology, vol. 14, pp. 553-554559 561, 2000.
J. C. King, Treanor, J., Fast, P. E., Wolff, M. C., Yan, L., Iacuzio, D., Readmond, B., O’Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults, J Infec Dis, vol. 181, pp. 725-8, 2000.
J. Kurzberg, Wagner, E. L., Cairo, M. S., Carter, S. L., Kernan, N. A., Jensen, L., Gindy, L., Issitt, L., and Fraser, J. K., The Cord Blood Transplantation (COBLT) Study: The First Two Years of Recruitment and Collection by the COBLT Cord Blood Banks, in American Society for Blood and Marrow Transplantation Annual Meeting, Anaheim, CA, 2000.
W. A. Gahl, Kuehl, E. M., Iwata, F., Lindblad, A., and Kaiser-Kupfer, M. I., Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eye drops, Mol Gene Metab., vol. 71, pp. 100-20, 2000.
B. R. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine, J Infec Dis, vol. 181, pp. 11133-7, 2000.
J. Copley, Staffeld, C., Lindberg, J., Bailey, C., and Van Veldhuisen, P., Cyclosporine to tacrolimus: rejection, toxicity and cardiovascular risks, 2000.
S. Sabbaj, Mulligan, M. J., Hsieh, R. H., Belshe, R. B., and , Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group, AIDS Res HumRetroviruses, vol. 14, pp. 1365-74, 2000.